Association of types of dyspnea including ‘bendopnea’ with cardiopulmonary disease in primary care;Associação dos tipos de dispneia e da “flexopneia” com as patologias cardiopulmonares nos cuidados de saúde primários

Revista Portuguesa de Cardiologia

Volumn 36, Issue 3, 2017, Pages 179-186

  Martínez Cerón, Diana María ^a   Garcia Rosa, Maria Luiza ^a   Lagoeiro Jorge, Antônio Jose ^a   de Andrade Martins, Wolney ^a   Tinoco Mesquita, Evandro ^a   Di Calafriori Freire, Monica ^a   da Silva Correia, Dayse Mary ^a   Kang, Hye Chung ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Bendopnea; Dyspnea; Heart failure; Paroxysmal nocturnal dyspnea; Primary care

Indexed keywords

ADULT; AGED; ARTICLE; BENDOPNEA; BRAZIL; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSPNEA; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; ORTHOPNEA; PAROXYSMAL DYSPNEA; PHENOTYPE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RESPIRATORY FAILURE; CLASSIFICATION; COMPLICATION; FEMALE; LUNG DISEASE; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 85012897710     PISSN: 08702551     EISSN: 21742030     Source Type: Journal    
DOI: 10.1016/j.repc.2016.08.007     Document Type: Article

References (47)

1. 1 Tessier, J.F., Nejjari, C., Letenneur, L., et al. Dyspnea and 8‐year mortality among elderly men and women: the PAQUID cohort study. Eur J Epidemiol. 17 (2001), 223–229.
2. 2 Landahl, S., Steen, B., Svanborg, A., Dyspnea in 70‐year‐old people. Acta Med Scand. 207 (1980), 225–230.
3. 3 Ahmed, A., Allman, R.M., Aronow, W.S., et al. Diagnosis of heart failure in older adults: predictive value of dyspnea at rest. Arch Gerontol Geriatr. 38 (2004), 297–307.
4. 4 Friedman, M.M., Older adults’ symptoms and their duration before hospitalization for heart failure. Heart Lung. 26 (1997), 169–176.
5. 5 Vuckovic, K.M., DeVon, H.A., Piano, M.R., Measurement of dyspnea in ambulatory African Americans with heart failure and a preserved or reduced ejection fraction. J Cardiovasc Nurs. 31 (2016), 13–21.
6. 6 West, R.L., Hernandez, A.F., O'Connor, C.M., et al. A review of dyspnea in acute heart failure syndromes. Am Heart J. 160 (2010), 209–214.
7. 7 Simon, P.M., Schwartzstein, R.M., Weiss, J.W., et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 142 (1990), 1009–1014.
8. 8 Mahler, D.A., Harver, A., Lentine, T., et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med. 154 (1996), 1357–1363.
9. 9 Ho, K.K., Anderson, K.M., Kannel, W.B., et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 88 (1993), 107–115.
10. 10 Fan, X., Meng, Z., The mutual association between depressive symptoms and dyspnea in Chinese patients with chronic heart failure. Eur J Cardiovasc Nurs. 14 (2015), 310–316.
11. 11 Mukerji, V., Dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Walker, H.K., Hall, W.D., Hurst, J.W., (eds.) Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition, 1990, Butterworths, Boston Chapter 11.
12. 12 Thibodeau, J.T., Turer, A.T., Gualano, S.K., et al. Characterization of a novel symptom of advanced heart failure: bendopnea. JACC Heart Fail. 2 (2014), 24–31.
13. 13 Brandon, N., Mehra, M.R., “Flexo‐dyspnea”: a novel clinical observation in the heart failure syndrome. J Heart Lung Transplant. 32 (2013), 844–845.
14. 14 Rosa, M.L.G., Mesquita, E.T., Jorge, A.J., et al. Prevalence of chronic diseases in individuals assisted by the family health program in Niteroi, Brazil: evaluation of selection bias and protocol. Int J Med Res Health Sci. 4 (2015), 587–596.
15. 15 Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol 2010; 95(1 supl.1): 1‐51.
16. 16 Jorge, A.J., Freire, M.D., Ribeiro, M.L., et al. Utility of B type natriuretic peptide measurement in outpatients with heart failure with preserved ejection fraction. Rev Port Cardiol. 32 (2013), 647–652.
17. 17 Dickstein, K., Cohen-Solal, A., Filippatos, G., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 29 (2008), 2388–2442.
18. 18 Paulus, W.J., Tschope, C., Sanderson, J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 28 (2007), 2539–2550.
19. 19 Felker, G.M., Shaw, L.K., Stough, W.G., et al. Anemia in patients with heart failure and preserved systolic function. Am Heart J. 151 (2006), 457–462.
20. 20 Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med. 16 (2001), 606–613.
21. 21 Santos, I.S., Tavares, B.F., Munhoz, T.N., et al. Sensitivity and specificity of the Patient Health Questionnaire‐9 (PHQ‐9) among adults from the general population. Cad Saude Pública. 29 (2013), 1533–1543.
22. 22 Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 854 (1995), 1–452.
23. 23 American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care. 34:Suppl 1 (2011), S11–S61.
24. 24 Shiber, J.R., Santana, J., Dyspnea. Med Clin North Am. 90 (2006), 453–479.
25. 25 McKee, P.A., Castelli, W.P., McNamara, P.M., et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 285 (1971), 1441–1446.
26. 26 Carlson, K.J., Lee, D.C., Goroll, A.H., et al. An analysis of physicians’ reasons for prescribing long‐term digitalis therapy in outpatients. J Chronic Dis. 38 (1985), 733–739.
27. 27 Bozkurt, B., Mann, D.L., Cardiology patient page. Shortness of breath. Circulation. 108 (2003), e11–e13.
28. 28 Albert, N., Trochelman, K., Li, J., et al. Signs and symptoms of heart failure: are you asking the right questions. Am J Crit Care. 19 (2010), 443–452.
29. 29 Katon, W.J., Richardson, L., Lozano, P., et al. The relationship of asthma and anxiety disorders. Psychosom Med. 66 (2004), 349–355.
30. 30 Herr, J.K., Salyer, J., Lyon, D.E., et al. Heart failure symptom relationships: a systematic review. J Cardiovasc Nurs. 29 (2014), 416–422.
31. 31 Scano, G., Gigliotti, F., Stendardi, L., et al. Dyspnea and emotional states in health and disease. Respir Med. 107 (2013), 649–655.
32. 32 Martínez-Moragón, E., Perpiñá, M., Belloch, A., et al. Determinants of dyspnea in patients with different grades of stable asthma. J Asthma. 40 (2003), 375–382.
33. 33 Neuman, A., Gunnbjörnsdottir, M., Tunsäter, A., et al. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med. 100 (2006), 1843–1849.
34. 34 Tiller, J., Pain, M., Biddle, N., Anxiety disorder and perception of inspiratory resistive loads. Chest. 91 (1987), 547–551.
35. 35 Hawkins, N.M., Petrie, M.C., Jhund, P.S., et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 11 (2009), 130–139.
36. 36 Caroci Ade, S., Lareau, S.C., Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. Heart Lung. 33 (2004), 102–110.
37. 37 Locke, E., Thielke, S., Diehr, P., et al. Effects of respiratory and non‐respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. COPD. 10 (2013), 588–596.
38. 38 Bowden, J.A., To, T.H., Abernethy, A.P., et al. Predictors of chronic breathlessness: a large population study. BMC Public Health., 12., 2011, 33.
39. 39 Babb, T.G., Wyrick, B.L., DeLorey, D.S., et al. Fat distribution and end‐expiratory lung volume in lean and obese men and women. Chest. 134 (2008), 704–711.
40. 40 Kress, J.P., Pohlman, A.S., Alverdy, J., et al. The impact of morbid obesity on oxygen cost of breathing (VO(2 RESP)) at rest. Am J Respir Crit Care Med. 160 (1999), 883–886.
41. 41 Lagaay, A.M., van der Meij, J.C., Hijmans, W., Validation of medical history taking as part of a population based survey in subjects aged 85 and over. BMJ. 304 (1992), 1091–1092.
42. 42 Midthjell, K., Holmen, J., Bjørndal, A., et al. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord‐Trøndelag diabetes study. J Epidemiol Community Health. 46 (1992), 537–542.
43. 43 Kehoe, R., Wu, S.Y., Leske, M.C., et al. Comparing self‐reported and physician‐reported medical history. Am J Epidemiol. 139 (1994), 813–818.
44. 44 Haapanen, N., Miilunpalo, S., Pasanen, M., et al. Agreement between questionnaire data and medical records of chronic diseases in middle‐aged and elderly Finnish men and women. Am J Epidemiol. 145 (1997), 762–769.
45. 45 Lampe, F.C., Walker, M., Lennon, L.T., et al. Validity of a self‐reported history of doctor‐diagnosed angina. J Clin Epidemiol. 52 (1999), 73–81.
46. 46 Ministério da Saúde, Secretaria de Vigilância em Saúde, Secretaria de Atenção à Saúde, Instituto Nacional de Câncer, Coordenação de Prevenção e Vigilância. Inquérito domiciliar sobre comportamentos de risco e morbidade referida de doenças e agravos não‐transmissíveis: Brasil, 15 capitais e Distrito Federal, 2002‐2003. INCA, Rio de Janeiro. 2004.
47. 47 Barr, R.G., Herbstman, J., Speizer, F.E., et al. Validation of self‐reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 155 (2002), 965–971.